Thus, the decrease in NO bioavailability observed in obesity likely results from scavenging by ROS, as opposed to the altered production as seen in aging (although eNOS uncoupling can also occur in obesity) [77–79]. The gene discussed is NOS3; the disease is obesity due to melanocortin 4 receptor deficiency.